New diabetes clinical trial: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients

Published on: March 29, 2019 at 06:00PM
Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: TOL-3021;   Other: TOL-3021 Placebo
Sponsor:   Tolerion, Inc.
Not yet recruiting